Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL398110 (Uk-396,082, UK 396082, UK-396082) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Carboxypeptidase B1 (tissue)/Carboxypeptidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2552] [GtoPdb: 1593] [UniProtKB: P15086] | ||||||||
ChEMBL | Inhibition of human pancreatic carboxypeptidase B | B | 6.69 | pKi | 206 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 92-96 [PMID:19954973] |
Carboxypeptidase B in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4065] [UniProtKB: P09955] | ||||||||
ChEMBL | Inhibition of porcine pancreatic carboxypeptidase B | B | 6.69 | pKi | 206 | nM | Ki | J Med Chem (2007) 50: 6095-6103 [PMID:17990866] |
Carboxypeptidase B2 (plasma)/Carboxypeptidase B2 isoform A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3419] [GtoPdb: 1594] [UniProtKB: Q96IY4] | ||||||||
ChEMBL | Inhibition of active form of human recombinant TAFI assessed as substrate turnover every 15 seconds for 30 mins | B | 7.8 | pKi | 16 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 92-96 [PMID:19954973] |
GtoPdb | - | - | 8 | pKi | 10 | nM | Ki | J Med Chem (2007) 50: 6095-103 [PMID:17990866] |
ChEMBL | Inhibition of human TAFIa | B | 8 | pKi | 10 | nM | Ki | J Med Chem (2007) 50: 6095-6103 [PMID:17990866] |
ChEMBL | Inhibition of TAF1a in human plasma assessed as clot lysis | B | 5.3 | pIC50 | 5000 | nM | IC50 | Bioorg Med Chem (2014) 22: 2261-2268 [PMID:24588961] |
ChEMBL | Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysis | B | 6.35 | pIC50 | 450 | nM | IC50 | Bioorg Med Chem (2014) 22: 2261-2268 [PMID:24588961] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]